Articles with public access mandates - Jeffrey V LazarusLearn more
Not available anywhere: 15
Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: data for designing a cost‐effective elimination policy in Spain
J Crespo, A Cuadrado, C Perelló, J Cabezas, S Llerena, J Llorca, ...
Journal of viral hepatitis 27 (4), 360-370, 2020
Mandates: Government of Spain
HIV infection
LG Bekker, C Beyrer, N Mgodi, SR Lewin, S Delany-Moretlwe, B Taiwo, ...
Nature Reviews Disease Primers 9 (1), 42, 2023
Mandates: National Health and Medical Research Council, Australia
Elimination of hepatitis C virus infection among people who use drugs: ensuring equitable access to prevention, treatment, and care for all
J Grebely, B Hajarizadeh, JV Lazarus, J Bruneau, C Treloar, ...
International Journal of Drug Policy 72, 1-10, 2019
Mandates: National Health and Medical Research Council, Australia, Government of Spain
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in …
V Saludes, A Antuori, JV Lazarus, C Folch, S González-Gómez, ...
International Journal of Drug Policy 80, 102734, 2020
Mandates: Government of Spain
Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
A Palayew, H Razavi, SJ Hutchinson, GS Cooke, JV Lazarus
The Lancet Gastroenterology & Hepatology 5 (10), 948-953, 2020
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy
JV Lazarus, CA Picchio, D Guy, S Aleman, C James, FA Nava, A Øvrehus, ...
Clinics and Research in Hepatology and Gastroenterology 45 (2), 101564, 2021
Mandates: Banking Foundation "la Caixa", Government of Spain
Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain
P Ryan, J Valencia, G Cuevas, J Torres-Macho, J Troya, Á Pueyo, ...
International Journal of Drug Policy 96, 103424, 2021
Mandates: Government of Spain
Development of a scale for measuring collaboration between physicians and nurses in primary health-care teams
L Jaruseviciene, A Kontrimiene, A Zaborskis, I Liseckiene, G Jarusevicius, ...
Journal of interprofessional care, 2019
Mandates: Research Council of Lithuania
Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point‐of‐care
J Valencia, JV Lazarus, FC Ceballos, J Troya, G Cuevas, S Resino, ...
Liver International 42 (2), 309-319, 2022
Mandates: Government of Spain
Patient satisfaction with HIV care service in Spain: results from a cross-sectional patient survey
C Burgui, D Guy, U Fresán, M Kall, J Castilla, JV Lazarus
AIDS care 35 (6), 892-898, 2023
Mandates: Government of Spain
France removes hepatitis C treatment prescriber restrictions—but what is the impact of the delay for key populations?
F Marcellin, P Roux, JV Lazarus, B Rolland, P Carrieri
Liver International 39 (12), 2019
Mandates: Agence Nationale de la Recherche
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease
JV Lazarus, M Villota-Rivas, C Jiménez-González, A Santos-Laso, ...
Clinics in Liver Disease 27 (2), 515-533, 2023
Mandates: Government of Spain
The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe
A Mocroft, A Geressu, C Beguelin, JM Llibre, JV Lazarus, J Tomazic, ...
AIDS 37 (1), 91-103, 2023
Mandates: Swiss National Science Foundation, Danish National Research Foundation …
Liver diseases: A sanitary and social challenge for Europe in the XXI Century. Results of EASL-Lancet Comission
P Ginès, M Buti, JV Lazarus, B Sangro
Medicina Clínica (English Edition) 159 (12), 598-603, 2022
Mandates: European Commission, Government of Spain
Steatotic liver disease and HIV: an agenda for 2030
JM Pericàs, AK Arora, C Riebensahm, A Jiménez-Masip, AR Mena, ...
The Lancet HIV, 2024
Mandates: European Commission
Available somewhere: 150
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic …
SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The Lancet 392 (10159), 1789-1858, 2018
Mandates: Swiss National Science Foundation, Bill & Melinda Gates Foundation, US …
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ...
The lancet 396 (10258), 1204-1222, 2020
Mandates: Bill & Melinda Gates Foundation, National Health and Medical Research …
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to …
C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ...
JAMA oncology 3 (4), 524-548, 2017
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of …
GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The lancet 392 (10159), 1736-1788, 2018
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, US Agency …
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and …
JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ...
The Lancet 392 (10159), 1923-1994, 2018
Mandates: US National Science Foundation, Bill & Melinda Gates Foundation, US National …
Publication and funding information is determined automatically by a computer program